Forward Pharma A/S (symbol FWP in the US) used to get revenue from a royalty agreement on dimethyl fumarate. It lost patent opposition actions and entered a legal settlement. It is using settlement proceeds to fund the last lawsuit, related to a European patent. If all litigation works out well for the company the earliest time the company expects to receive royalties is somewhere in 2026.
Forward Pharma: promising net-net with a tax risk
Forward Pharma: promising net-net with a tax…
Forward Pharma: promising net-net with a tax risk
Forward Pharma A/S (symbol FWP in the US) used to get revenue from a royalty agreement on dimethyl fumarate. It lost patent opposition actions and entered a legal settlement. It is using settlement proceeds to fund the last lawsuit, related to a European patent. If all litigation works out well for the company the earliest time the company expects to receive royalties is somewhere in 2026.